Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04819893

Study of the Involvement of Fatty Acids in Retinopathy of Prematurity: Relationship Between Retinopathy of Prematurity and the Rate of Expression of Transplacental Fatty Acid Receptors.

Status
Recruiting
Phase
Study type
Observational
Enrollment
135 (estimated)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The development of the retinal vascular network is completed during the third trimester of pregnancy and and the first 15 days of life of the newborn. This late maturation can be problematic in cases of preterm births and result in immature retinal vascularization, known as retinopathy of prematurity (ROP). Among the various factors influencing retinal vascular development, the tissue content of omega-3 polyunsaturated fatty acids (PUFAs) appears to be a crucial element. In a previous project, OMEGA-ROP, we showed a difference in the blood bioavailability of omega-3 PUFAs in infants born at less than 28 weeks of amenorrhea who develop ROP compared to healthy newborns with no retinopathy. This study also showed that mothers experienced variations in the blood levels of omega-3 PUFAs that were contrary to the types of variations observed in their children. This suggests a sequestration of omega-3 PUFAs in the mothers of children who will develop ROP. This new project aims to better understand the underlying molecular mechanisms by studying the expression levels of placental fatty acid receptors in relation to the development of ROP in newborns.

Conditions

Interventions

TypeNameDescription
BIOLOGICALMaternal blood sampling5 mL sample of venous blood on arrival at the maternity ward in accordance with standard protocols
BIOLOGICALUmbilical cord blood sampling0.5mL sample from the umbilical cord after childbirth standard protocols
BIOLOGICALPlacenta samplingSampling of 3 cotyledons by cutting across the thickness of the placenta
OTHERData collectionNewborn, Maternal and Premature Retinopathy Screening Data Collection

Timeline

Start date
2021-04-20
Primary completion
2027-02-01
Completion
2027-02-01
First posted
2021-03-29
Last updated
2025-09-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04819893. Inclusion in this directory is not an endorsement.